All filters
Slidesets
Persistence on F/TAF versus F/TDF for HIV Pre-Exposure Prophylaxis: A Real-World Evidence Analysis in the United States - Corie Cruz Beniasians
Presented at:
HIV Prevention Summit 2021
Slidesets
Community PrEP Service delivery for Female Sex Workers in Ghana - Guro Lundby Sorensen
Presented at:
HIV Prevention Summit 2021
Slidesets
Intimate partner violence and gender-based violence among people living with HIV in southern Nigeria - Chika Okafor
Presented at:
HIV Prevention Summit 2021
Slidesets
Uptake of HIV post-exposure prophylaxis, completion rates and selfreported reasons for non-completion among health care workers at Mbarara Regional Referral Hospital - Musiime Muzoora Dan
Presented at:
HIV Prevention Summit 2021
Slidesets
WHO Perspective on HIV Prevention - What Are the Gaps - Rachel Baggaley, MBBS, MSc
Presented at:
HIV Prevention Summit 2021
Slidesets
Successes to Access PrEP and PEP End-User Perspective - Gcobisa Madlolo
Presented at:
HIV Prevention Summit 2021
Slidesets
Antibody Mediated Prevention of HIV - Myron Cohen, MD
Presented at:
HIV Prevention Summit 2021
Slidesets
Novel Drug Delivery Systems on the Horizon -Charles Flexner, MD
Presented at:
HIV Prevention Summit 2021
Slidesets
Overview of Clinical Data on the Safety and Efficacy of Antiretroviral Drugs for HIV - Roy M. Gulick, MD, MPH
Presented at:
HIV Prevention Summit 2021
Slidesets
Successes to Access PrEP and PEP End-User Perspective_Gcobisa Madlolo
Presented at:
HIV Prevention Summit 2021
Slidesets
Successful Models of PrEP Implementation - Francois Venter, MD
Presented at:
HIV Prevention Summit 2021
Slidesets
Why Don't Prescribers Prescribe - Douglas Krakower, MD
Presented at:
HIV Prevention Summit 2021
Slidesets
R&D Pipeline & Clinical Trial Design -Linda-Gail Bekker, DCH, FCP(SA), PhD
Presented at:
HIV Prevention Summit 2021
Slidesets
Case Discussion: ART - Experienced Patients with Virologic Failure -- Wei Cao
Presented at:
Chinese HIV Clinical Forum Educational Series 2021
Slidesets
Rapid Antiretroviral Therapy for HIV -- Yinzhong Shen
Presented at:
Chinese HIV Clinical Forum Educational Series 2021
Slidesets
COVID-19 Challenges and Scale-up in Access to Community-Based HCV Treatment for HIV/HCV Co-infected PWIDs in Ukraine - Zahedul Islam
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021
Slidesets
Dynamics and Peculiarities of AIDS Mortality in Minsk, Belarus - Shylava, Marharyta
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021
Slidesets
SARS-CoV-2 Antibody Seroprevalence in Previously Undiagnosed Persons in Tbilisi, Georgia: Results of Three Repeated Serosurveys - Akaki Abutidze
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021
Slidesets
HIV & COVID-19 Coinfection - Anca Streinu-Cercel, MD, PhD
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021
Slidesets
Update on COVID-19 Therapeutics - Daniel Kuritzkes, MD
Dr. Kuritzkes, Daniel
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021
Slidesets
HIV Prevention in High Risk Populations: Unique Challenges and Solutions - Jean-Michel Molina, MD, PhD
Dr. Molina, Jean-Michel
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021
Slidesets
Long-Acting Therapy for PrEP: How Will We Use it? - Luis Mendão
Mr. Mendão, Luis
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021
Slidesets
Rollout of PrEP in Europe: Success Stories and Challenges - Teymur Noori, MSc
Dr. Noori, Teymur
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021